COIN Investigators & Staff - Seattle-Denver Center of Innovation (COIN)
Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

Seattle-Denver Center of Innovation (COIN)

Menu
Menu

Quick Links

Veterans Crisis Line Badge
My healthevet badge
 

COIN Investigators & Staff

COIN Affiliate Investigator

 

David Saxon, MD
Title: Chief of Endocrinology, Rocky Mountain Regional VA Medical Center
Assistant Professor, Medicine-Endocrinology/Metabolism/Diabetes, University of Colorado
Contact: David.Saxon@va.gov
Location: Denver
University of Colorado webpage
See Dr. Saxon's Dimensions profile that includes: publications, grants, datasets, patents and clinical trials

Return to Top

Recent Publications

 

The following research fields have been used to summarize Dr. Saxon's publication (the number in parenthesis is the times that research field has appeared). The categories are based on 22 publications with 191 citations of his work, 65% of his publications have at least 1 citation:

  • Clinical Research (14)
  • Diabetes (12)
  • Cardiovascular (7)
  • Nutrition (6)
  • Clinical Trials and Supportive Activities (5)
  • Prevention (5)
  • Heart Disease (5)
  • Health Services (3)
  • Obesity (3)
  • Patient Safety (3)
  • Atherosclerosis (2)

 

2022

 

Raghavan S, Warsavage T, Liu WG, Raffle K, Josey K, Saxon DR, Phillips LS, Caplan L, Reusch JEB. Trends in Timing of and Glycemia at Initiation of Second-line Type 2 Diabetes Treatment in U.S. Adults. Diabetes Care. 2022 Mar 28:dc212492. doi: 10.2337/dc21-2492. Epub ahead of print.
PMID: 35344584

Kobe EA, Lewinski AA, Jeffreys AS, Smith VA, Coffman CJ, Danus SM, Sidoli E, Greck BD, Horne L, Saxon DR, Shook S, Aguirre LE, Esquibel MG, Evenson C, Elizagaray C, Nelson V, Zeek A, Weppner WG, Scodellaro S, Perdew CJ, Jackson GL, Steinhauser K, Bosworth HB, Edelman D, Crowley MJ. Implementation of an Intensive Telehealth Intervention for Rural Patients with Clinic-Refractory Diabetes. J Gen Intern Med. 2022 Jan 3:1–9. doi: 10.1007/s11606-021-07281-8. Epub ahead of print. PMCID: PMC8722663.
PMID: 34981358.

2021

 

Glodowski M, Christen S, Saxon DR, Hegele RA, Eckel RH. Novel PPARG mutation in multiple family members with chylomicronemia. J Clin Lipidol. 2021 Mar 26:S1933-2874(21)00057-X. doi: 10.1016/j.jacl.2021.03.006. Epub ahead of print.
PMID: 33832869.

Thompson MA, Fuhlbrigge AL, Pearson DW, Saxon DR, Oberst-Walsh LA, Thomas JF. Building eConsult (Electronic Consults) Capability at an Academic Medical Center to Improve Efficiencies in Delivering Specialty Care. J Prim Care Community Health. 2021 Jan-Dec;12:21501327211005303. doi: 10.1177/21501327211005303.
PMID: 33759622.

Kheniser K, Saxon DR, Kashyap SR. Long-term weight loss strategies for obesity. J Clin Endocrinol Metab. 2021 Feb 17:dgab091. doi: 10.1210/clinem/dgab091. Epub ahead of print.
PMID: 33595666.

Saxon DR, Kaboli PJ, Haraldsson B, Wilson C, Ohl M, Augustine MR. Growth of electronic consultations in the Veterans Health Administration. Am J Manag Care. 2021 Jan;27(1):12-19. doi: 10.37765/ajmc.2021.88572.
PMID: 33471457.

2020

 

Salahuddin T, Richardson V, McNeal DM, Henderson K, Hess PL, Raghavan S, Saxon DR, Valle JA, Waldo SW, Ho PM, Schwartz GG. Potential unrealized mortality benefit of glucagon-like peptide-1 receptor agonists and sodium-glucose co-transport-2 inhibitors: A report from the Veterans Health Administration Clinical Assessment, Reporting and Tracking program. Diabetes Obes Metab. 2021 Jan;23(1):97-105. doi: 10.1111/dom.14193. Epub 2020 Oct 3.
PMID: 32902128.

Reiter-Brennan C, Cainzos-Achirica M, Soroosh G, Saxon DR, Blaha MJ, Eckel RH. Cardiometabolic medicine - the US perspective on a new subspecialty. Cardiovasc Endocrinol Metab. 2020 Jul 16;9(3):70-80. doi: 10.1097/XCE.0000000000000224. eCollection 2020 Sep.
PMID: 32803138.

Saxon DR, Reiter-Brennan C, Blaha MJ, Eckel RH. Cardiometabolic Medicine: Development of a New Subspecialty. J Clin Endocrinol Metab. 2020 Jul 1;105(7):dgaa261. doi: 10.1210/clinem/dgaa261.
PMID: 32407515.

2019

 

Saxon DR, Chaussee EL, Juarez-Colunga E, Tsai AG, Iwamoto SJ, Speer RB, Heyn H, Kealey EH, Bessesen DH. A Toolbox Approach to Obesity Treatment in Urban Safety-Net Primary Care Clinics: a Pragmatic Clinical Trial. J Gen Intern Med. 2019 Nov;34(11):2405-2413. doi: 10.1007/s11606-019-05222-0. Epub 2019 Aug 26.
PMID: 31485965.

2018

 

Raghavan S, Liu WG, Saxon DR, Grunwald GK, Maddox TM, Reusch JEB, Berkowitz SA, Caplan L. Oral diabetes medication monotherapy and short-term mortality in individuals with type 2 diabetes and coronary artery disease. BMJ Open Diabetes Res Care. 2018 Jun 15;6(1):e000516. doi: 10.1136/bmjdrc-2018-000516. eCollection 2018.

Raghavan S, Liu WG, Michael Ho P, Plomondon ME, Barón AE, Caplan L, Joynt Maddox KE, Magid D, Saxon DR, Voils CI, Bradley SM, Maddox TM. Coronary artery disease severity modifies associations between glycemic control and both mortality and myocardial infarction. J Diabetes Complications. 2018 May;32(5):480-487. doi: 10.1016/j.jdiacomp.2018.01.010. Epub 2018 Jan 31.

Saxon DR, Rasouli N, Eckel RH. Pharmacological Prevention of Cardiovascular Outcomes in Diabetes Mellitus: Established and Emerging Agents. Drugs. 2018 Feb;78(2):203-214. doi: 10.1007/s40265-017-0857-3.

return to top go